Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 162 of 1,261
  1. US 11793888

    Methods and compositions for engineering immunity

    Sangamo Therapeutics, Inc. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  2. US 11793810

    Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  3. US 11793177

    Animal model of Angelman Syndrome

    The Regents of the University of California · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  4. US 11793796

    Inhibition of crystal growth of roflumilast

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  5. US 11795176

    Solid forms of Alpha-1062 gluconate

    ALPHA COGNITION INC. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  6. US 11793776

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  7. US 11793870

    Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  8. US 11795192

    Antimicrobial compounds, compositions, and uses thereof

    Lakewood Amedex, Inc. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  9. US 11795130

    Process for separating a constituent/cannabinoid using a chromatographic resin

    KAZMIRA LLC. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  10. US 11793912

    Cross-linked fatty acid-based biomaterials

    ATRIUM MEDICAL CORPORATION · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  11. US 11795156

    Bicyclic carboxamides and methods of use thereof

    TEMPEST THERAPEUTICS, INC. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  12. US 11793777

    Methods and compositions for treating conditions associated with an abnormal inflammatory response

    First Wave Bio, Inc. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  13. US 11793780

    Prodrugs of treprosiinil

    United Therapeutics Corporation · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  14. US 11793815

    Oxindoles and methods of use thereof

    Aligos Therapeutics, Inc. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  15. US 11793806

    Pyruvate kinase activators for use in therapy

    Agios Pharmaceuticals, Inc. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  16. US 11793812

    Methods of treating endometriosis

    Takeda Pharmaceutical Company Limited · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  17. US 11793855

    TFPI inhibitors and methods of use

    Takeda Pharmaceutical Company Limited · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  18. US 11793871

    Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  19. US 11793825

    Biomarkers for predicting responsiveness to decitabine therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  20. US 11795443

    Uses of adenosine base editors

    Beam Therapeutics Inc. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  21. CA 3255134

    COMPOSITION D'ALLERGÈNE D'ARACHIDE

    ALK ABELLO AS [DK] · Granted Oct 19, 2023 · Expires Oct 14, 2043

    granted
  22. US 11787869

    Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness

    Dyne Therapeutics, Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted
  23. US 11787867

    Anti-GITR antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted
  24. US 11787833

    Modified cyclic dinucleoside compounds as sting modulators

    Aligos Therapeutics, Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.